Ningning Ding

Zhongguancun Life Science Park
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

NOTCH1 Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 Trial.

NOTCH1 Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 03, 2025

Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health-related quality of life in Asian patients.

Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health-related quality of life in Asian patients.

Journal: Current medical research and opinion
Published: October 17, 2023

Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302.

Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302.

Journal: Esophagus : official journal of the Japan Esophageal Society
Published: July 11, 2023

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study.

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2022

Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study.

Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study.

Journal: Clinical lung cancer
Published: March 23, 2020

Erratum: Spread through air spaces predicts a worse survival in patients with stage I adenocarcinomas >2 cm after radical lobectomy.

Erratum: Spread through air spaces predicts a worse survival in patients with stage I adenocarcinomas >2 cm after radical lobectomy.

Journal: Journal of thoracic disease
Published: July 10, 2019

Spread through air spaces predicts a worse survival in patients with stage I adenocarcinomas >2 cm after radical lobectomy.

Spread through air spaces predicts a worse survival in patients with stage I adenocarcinomas >2 cm after radical lobectomy.

Journal: Journal of thoracic disease
Published: November 13, 2018

The current optimal multimodality treatments for oesophageal squamous-cell carcinoma: A systematic review and meta-analysis.

The current optimal multimodality treatments for oesophageal squamous-cell carcinoma: A systematic review and meta-analysis.

Journal: International journal of surgery (London, England)
Published: September 11, 2018

Predictors of lymph node metastasis and possible selective lymph node dissection in clinical stage IA non-small cell lung cancer.

Predictors of lymph node metastasis and possible selective lymph node dissection in clinical stage IA non-small cell lung cancer.

Journal: Journal of thoracic disease
Published: September 04, 2018

Prognostic factors in curatively resected pathological stage I lung adenocarcinoma.

Prognostic factors in curatively resected pathological stage I lung adenocarcinoma.

Journal: Journal of thoracic disease
Published: January 10, 2018

Experiences in the management of anastomotic leakages and analysis of the factors affecting leakage healing in patients with esophagogastric junction cancer.

Experiences in the management of anastomotic leakages and analysis of the factors affecting leakage healing in patients with esophagogastric junction cancer.

Journal: Journal of thoracic disease
Published: March 10, 2017

Advances in Lymph Node Metastasis and the Modes of Lymph Node 
Dissection in Early Stage Non-small Cell Lung Caner

Advances in Lymph Node Metastasis and the Modes of Lymph Node 
Dissection in Early Stage Non-small Cell Lung Caner

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: June 24, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026